Patrick Irving Eacho
5Patents
3h-index
15Co-inventors
50Inventor score
Filing activity: Aug 4, 1998 → May 2, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7217727B2 | Phospholipase inhibitors | Chemistry; Metallurgy | 14 | Expired |
| US7595403B2 | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors | Chemistry; Metallurgy | 14 | Expired |
| US5908859A | Benzothiophenes for inhibiting hyperlipidemia | Chemistry; Metallurgy | 5 | Expired |
| US8048880B2 | Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapies | Human Necessities | 0 | Active |
| US6448422B1 | Chromogenic compound | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.